Our current clinical projects

Proprietary

Project & Mechanism
Disease areas
Research
Preclinical
Phase I
Phase II
Phase III
Market

Remetinostat

HDAC inhibitor (topical)

Cutaneous T-cell lymphoma (MF)

Basal cell carcinoma1)

Birinapant

SMAC mimetic (intravenous)

MSS colorectal cancer (Keytruda® combination)

Head & Neck cancer (with radiation)2)

MIV-818

Nucleotide DNA polymerase inhibitor (oral)

Hepatocellular carcinoma

MIV-828

Treatment of blood cancer (intravenous)

Blood cancer (acute myeloid leukemia)

MIV-711

Cathepsin K inhibitor (oral)

Osteoarthritis

1) Investigator sponsored study at Stanford U.

2) Investigator sponsored study at NCI, USA.

Partnerships

Project & Mechanism
Disease areas
Research
Preclinical
Phase I
Phase II
Phase III
Market

MIV-802

Nucleotide NS5B polymerase inhibitor

Hepatitis C

Xerclear® (Zoviduo®)

Hydrocortisone and aciclovir combination

Labial herpes

Our current clinical projects

Proprietary

Remetinostat

HDAC inhibitor (topical)

  • Mechanism

    HDAC inhibitor (topical)

  • Disease area

    Cutaneous T-cell lymphoma (MF)

    Phase II

    Basal cell carcinoma1)

    Phase II

Birinapant

SMAC mimetic (intravenous)

  • Mechanism

    SMAC mimetic (Intravenous)

  • Disease area

    MSS colorectal cancer (Keytruda® combination)

    Phase II

    Head & Neck cancer (with radiation)2)

    Phase I

MIV-818

Nucleotide DNA polymerase inhibitor (oral)

  • Mechanism

    Nucleotide DNA polymerase inhibitor (oral)

  • Disease area

    Hepatocellular carcinoma

    Phase I

MIV-828

Treatment of blood cancer (intravenous)

  • Mechanism

    Nucleotide DNA Polymerase inhibitor (intravenous)

  • Disease area

    Blood cancer (acute myeloid leukemia)

    Research

MIV-711

Cathepsin K inhibitor (oral)

  • Mechanism

    Cathepsin K inhibitor

  • Disease area

    Osteoarthritis

    Phase II

1) Investigator sponsored study at Stanford U.

2) Investigator sponsored study at NCI, USA.

Partnerships

MIV-802

Nucleotide NS5B polymerase inhibitor

  • Mechanism

    Nucleotide NS5B polymerase inhibitor

  • Disease area

    Hepatitis C

    Preclinical

Xerclear® (Zoviduo®)

Hydrocortisone and aciclovir combination

  • Mechanism

    Hydrocortisone and aciclovir combination

  • Disease area

    Labial herpes

    Market